3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers

Details for Australian Patent Application No. 2007233173 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Sui, Zhihua; Lanter, James C.

Agent Shelston IP

Pub. Number AU-A-2007233173

PCT Pub. Number WO2007/115071

Priority 60/788,382 31.03.06 US

Filing date 29 March 2007

Wipo publication date 11 October 2007

International Classifications

C07D 307/94 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/443 (2006.01)

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

30 October 2008 PCT application entered the National Phase

  PCT publication WO2007/115071 Priority application(s): WO2007/115071

25 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007233179-Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators

2007233155-Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery